The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer

Imagem de Miniatura
Arquivos
art_KLIMIS_The_Burden_of_Uncontrolled_Cardiovascular_Risk_Factors_in_2023.PDF (912.41 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
KLIMIS, Harry
PINTHUS, Jehonathan H.
AGHEL, Nazanin
DUCEPPE, Emmanuelle
FRADET, Vincent
BROWN, Ian
SIEMENS, D. Robert
SHAYEGAN, Bobby
KLOTZ, Laurence
LUKE, Patrick P.
Citação
JACC: CARDIOONCOLOGY, v.5, n.1, p.70-81, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND Cardiovascular disease (CVD) incidence is higher in men with prostate cancer (PC) than without. OBJECTIVES We describe the rate and correlates of poor cardiovascular risk factor control among men with PC. METHODS We prospectively characterized 2,811 consecutive men (mean age 68 +/- 8 years) with PC from 24 sites in Canada, Israel, Brazil, and Australia. We defined poor overall risk factor control as >= 3 of the following: suboptimal low-density lipoprotein cholesterol (>2 mmol/L if Framingham Risk Score [FRS] >= 15 and >= 3.5 mmol/L if FRS <15), current smoker, physical inactivity (<600 MET min/wk), suboptimal blood pressure (BP) (>= 140/90 mm Hg if no other risk factors, systolic BP >= 120 mm Hg if known CVD or FRS >= 15, and >= 130/80 mm Hg if diabetic), and waist:hip ratio >0.9. RESULTS Among participants (9% with metastatic PC and 23% with pre-existing CVD), 99% had >= 1 uncontrolled cardiovascular risk factor, and 51% had poor overall risk factor control. Not taking a statin (odds ratio [OR]: 2.55; 95% CI: 2.00-3.26), physical frailty (OR: 2.37; 95% CI: 1.51-3.71), need for BP drugs (OR: 2.36; 95% CI: 1.84-3.03), and age (OR per 10-year increase: 1.34; 95% CI: 1.14-1.59) were associated with poor overall risk factor control after adjustment for education, PC characteristics, androgen deprivation therapy, depression, and Eastern Cooperative Oncology Group functional status. CONCLUSIONS Poor control of modifiable cardiovascular risk factors is common in men with PC, highlighting the large gap in care and the need for improved interventions to optimize cardiovascular risk management in this population. (J Am Coll Cardiol CardioOnc 2023;5:70-81) (c) 2023 The Authors.
Palavras-chave
androgen deprivation therapy, cardiovascular disease prevention, cardiovascular risk, prospective, prostate cancer
URI
https://observatorio.fm.usp.br/handle/OPI/53869
Referências
  1. Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070
  2. Ahisar Y, 2021, J NUTR HEALTH AGING, V25, P1023, DOI 10.1007/s12603-021-1673-8
  3. Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032
  4. Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010, 10.1016/j.jacc.2019.03.009]
  5. Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165
  6. Butler SS, 2021, CANCER-AM CANCER SOC, V127, P2213, DOI 10.1002/cncr.33486
  7. Canadian Cardiovascular Society, FRAM RISK SCOR
  8. Cheung AS, 2013, ANDROLOGY-US, V1, P583, DOI 10.1111/j.2047-2927.2013.00093.x
  9. Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182
  10. Cirne F, 2022, EUR HEART J-CARD PHA, V8, P253, DOI 10.1093/ehjcvp/pvab005
  11. Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
  12. Fervaha G, 2021, CUAJ-CAN UROL ASSOC, V15, P181, DOI 10.5489/cuaj.6912
  13. Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041
  14. Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
  15. Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4
  16. Gaye B, 2017, J AM COLL CARDIOL, V69, P3015, DOI 10.1016/j.jacc.2017.05.011
  17. Guo LL, 2017, CLIN CARDIOL, V40, P1339, DOI 10.1002/clc.22836
  18. Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1
  19. Houlden RL, 2018, CAN J DIABETES, V42, pS1, DOI 10.1016/j.jcjd.2017.10.001
  20. IPAQ Research Committee, 2005, GUIDELINES DATA PROC
  21. Klimis H, 2021, AM HEART J, V242, P33, DOI 10.1016/j.ahj.2021.08.009
  22. Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
  23. Leong DP, 2020, J UROLOGY, V203, P1109, DOI 10.1097/JU.0000000000000714
  24. Levine GN, 2010, CIRCULATION, V121, P833, DOI 10.1161/CIRCULATIONAHA.109.192695
  25. OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014
  26. Orkaby AR, 2019, J GERONTOL A-BIOL, V74, P373, DOI 10.1093/gerona/gly134
  27. Pearson GJ, 2021, CAN J CARDIOL, V37, P1129, DOI 10.1016/j.cjca.2021.03.016
  28. Pinthus JH, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.178
  29. PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
  30. Rabi DM, 2020, CAN J CARDIOL, V36, P596, DOI 10.1016/j.cjca.2020.02.086
  31. Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006
  32. Sun LV, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0070
  33. Townsend RR, 2020, HYPERTENSION, V76, P1667, DOI 10.1161/HYPERTENSIONAHA.120.14650
  34. Uchmanowicz B, 2019, INT J HYPERTENS, V2019, DOI 10.1155/2019/5245184
  35. Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567
  36. Visseren FL., 2021, EUR HEART J, V42, P3227, DOI [DOI 10.1093/EURHEARTJ/EHAB484, DOI 10.1093/eurjpc/zwab154, 10.1093/eurheartj/ehab484]
  37. Weiner AB, 2021, CANCER-AM CANCER SOC, V127, P2895, DOI 10.1002/cncr.33584
  38. Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1189, DOI 10.1289/ehp.10850
  39. Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
  40. Yusuf S, 2020, LANCET, V395, P795, DOI 10.1016/S0140-6736(19)32008-2
  41. Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177
  42. Zhang KW, 2020, CIRCULATION, V142

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - ODS/03